Stay Informed with the Latest Political News on Politics Affairs
Bringing the First Global Cross-Disciplinary Immersive Entertainment Product BEIJING,May 24,2024-- In a strategic move to enhance its international market presence,Innomix is developing and producing
May 30, 2024JINAN,China,May 24,2024-- Recently,Inspur signed strategic cooperation agreements with Malaysia\'s large data center operator and Singapore\'s A3 Capital to jointly promote the development of the data
May 30, 2024TAIPEI,May 24,2024-- DEKRA,the automotive technology service provider recognized by EU government agencies,announced that it has successfully audited VicOne,a subsidiary of the cybersecurity giant Tr
May 30, 2024TORONTO,May 24,2024-- Visionary Holdings Inc. (the "Company") (NASDAQ: GV),a private education provider with technology of artificial intelligence and life science on the cutting edge,with s
May 30, 2024TORONTO,May 24,2024-- Visionary Holdings Inc. ("we",or the "Company") (NASDAQ: GV),a private education provider with technology of artificial intelligence and life science on the c
May 30, 2024BEIJING,May 24,2024--Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"),China\'s leading auto insurance technology platform,today announced it will host a conference call
May 30, 2024SHANGHAI,May 24,2024-- Xiao-I Corporation (NASDAQ: AIXI) ("Xiao-I" or the "Company"),a leading AI company announces an important partnership with a major Chinese banking institutio
May 30, 2024SHANGHAI,May 24,2024-- SpaceX\'s Starlink recently officially announced their high-speed internet constellation is now connecting more than 3 million people with high-speed internet across nearly 100
May 30, 2024HONG KONG,May 24,2024-- Digital transformation specialistGienTech and China Computer Federation (CCF) Digital Finance successfully co-hosted the "2024 GienTech Digital Transformation Conference&
May 30, 2024SHANGHAI,May 24,2024-- Shanghai Juncell Therapeutics Co.,Ltd. (Juncell Therapeutics),a clinical-stage biotech developing innovative Tumor-Infiltrating Lymphocyte (TIL) therapies for cancers,announced
May 30, 2024